查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1665268

神经假体市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测

Neuroprosthetics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球神经假体市场价值为 155 亿美元，并有望实现显着增长，预计 2025 年至 2034 年期间的复合年增长率为 12.7%。 这一增长主要归因于神经系统疾病患病率的上升和尖端可穿戴神经假体技术的日益普及。发展中地区医疗保健可近性的增强以及患者和医疗保健提供者对神经假体变革益处的认识不断提高，进一步推动了需求。此外，政府对先进神经系统治疗的支持和资助计画正在拓展这些创新设备的潜力。

神经假体市场 - IMG1

从类型来看，运动义肢将占据市场主导地位，预计复合年增长率为 12.5%，到 2034 年将达到 230 亿美元。这些技术在復健治疗中发挥越来越重要的作用，有助于恢復失去的运动功能并巩固运动义肢的强大市场地位。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 155亿美元
预测值 510亿美元
复合年增长率 12.7％

在按技术分类时，脊髓刺激 (SCS) 在 2024 年以 36.7% 的份额领先市场。它们在治疗慢性疼痛方面已被证实有效，并成为患者和医疗保健提供者的首选解决方案，从而确保了其持续的市场主导地位。

在美国，神经假体市场在 2024 年的规模为 66 亿美元，预计到 2034 年的复合年增长率将达到 12%。强劲的报销政策和领先製造商的存在进一步促进了市场扩张。医疗技术的不断进步和对神经系统护理的不断加强，使美国牢牢占据全球神经假体行业创新和成长的重要枢纽地位。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 神经系统疾病盛行率上升
      • 神经技术的进步
      • 穿戴式神经假体的采用日益广泛
    • 产业陷阱与挑战
      • 设备成本高
  • 成长潜力分析
  • 监管格局
  • 报销场景
  • 技术格局
  • 差距分析
  • 波特的分析
  • PESTEL 分析
  • 未来市场趋势

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第 5 章：市场估计与预测：按类型，2021 年至 2034 年

  • 主要趋势
  • 运动义肢
  • 感觉义肢
  • 认知义肢

第 6 章：市场估计与预测：按应用，2021 年至 2034 年

  • 主要趋势
  • 运动障碍
    • 帕金森氏症
    • 癫痫
  • 生理障碍
    • 听觉障碍
    • 眼科疾病
    • 心臟疾病
    • 肾臟疾病
  • 认知障碍
    • 阿兹海默症
    • 严重忧郁

第 7 章：市场估计与预测：按技术，2021 年至 2034 年

  • 主要趋势
  • 脊髓刺激
  • 深部脑部刺激
  • 迷走神经刺激
  • 荐神经刺激
  • 经颅磁刺激

第 8 章：市场估计与预测：依最终用途，2021 年至 2034 年

  • 主要趋势
  • 医院
  • 诊所
  • 门诊手术中心
  • 其他最终用户

第 9 章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第十章：公司简介

  • Advanced Bionics
  • Boston Scientific
  • Cochlear
  • Kernel
  • LivaNova
  • Med-El
  • Medtronic
  • NDI
  • Neuropace
  • nevro
  • Retina Implant
  • Second Sight
  • Sonova
简介目录
Product Code: 12748

The Global Neuroprosthetics Market was valued at USD 15.5 billion in 2024 and is poised for remarkable growth, projected to expand at a CAGR of 12.7% from 2025 to 2034. This growth is largely attributed to the rising prevalence of neurological disorders and the increasing adoption of cutting-edge wearable neuroprosthetic technologies. Enhanced healthcare accessibility in developing regions and growing awareness of neuroprosthetics' transformative benefits among patients and healthcare providers are further driving demand. Additionally, government support and funding initiatives for advanced neurological treatments are broadening the potential of these innovative devices.

Neuroprosthetics Market - IMG1

By type, motor prosthetics are positioned to dominate the market, with a projected CAGR of 12.5%, reaching USD 23 billion by 2034. Groundbreaking advancements in brain-machine interfaces (BMIs) and neural control systems have revolutionized motor prosthetics, enabling seamless brain-to-device communication for natural and efficient movements. These technologies are playing an increasingly vital role in rehabilitation therapies, helping restore lost motor functions and solidifying the strong market presence of motor prosthetics.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$15.5 Billion
Forecast Value$51 Billion
CAGR12.7%

When categorized by technique, spinal cord stimulation (SCS) leads the market with a 36.7% share in 2024. SCS devices have become a cornerstone in the treatment of neuropathic pain, failed back surgery syndrome, and complex regional pain syndrome. Their proven efficacy in managing chronic pain has established them as the preferred solution for patients and healthcare providers alike, ensuring their sustained market dominance.

In the United States, the neuroprosthetics market accounted for USD 6.6 billion in 2024 and is expected to grow at a CAGR of 12% through 2034. Key factors fueling this growth include the country's aging population and the increasing incidence of neurological conditions such as Parkinson's disease and epilepsy. Robust reimbursement policies and the presence of leading manufacturers further bolster market expansion. Continuous advancements in medical technology and an intensified focus on neurological care firmly position the U.S. as a critical hub for innovation and growth in the global neuroprosthetics industry.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of neurological disorders
      • 3.2.1.2 Advancements in neurotechnology
      • 3.2.1.3 Growing adoption of wearable neuroprosthetics
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High costs of devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Reimbursement scenario
  • 3.6 Technology landscape
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Motor prosthetics
  • 5.3 Sensory prosthetics
  • 5.4 Cognitive prosthetics

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Motor disorders
    • 6.2.1 Parkinson disease
    • 6.2.2 Epilepsy
  • 6.3 Physiological disorders
    • 6.3.1 Auditory disorders
    • 6.3.2 Ophthalmic disorders
    • 6.3.3 Cardiac disorders
    • 6.3.4 Kidney disorders
  • 6.4 Cognitive disorders
    • 6.4.1 Alzheimer disease
    • 6.4.2 Severe depression

Chapter 7 Market Estimates and Forecast, By Technique, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Spinal cord stimulation
  • 7.3 Deep brain stimulation
  • 7.4 Vagus nerve stimulation
  • 7.5 Sacral nerve stimulation
  • 7.6 Transcranial magnetic stimulation

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Advanced Bionics
  • 10.2 Boston Scientific
  • 10.3 Cochlear
  • 10.4 Kernel
  • 10.5 LivaNova
  • 10.6 Med-El
  • 10.7 Medtronic
  • 10.8 NDI
  • 10.9 Neuropace
  • 10.10 nevro
  • 10.11 Retina Implant
  • 10.12 Second Sight
  • 10.13 Sonova